These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
|
UTG, INC.
|
||
|
(Exact name of registrant as specified in its charter)
|
||
|
Delaware
|
20-2907892
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
|
205 NORTH DEPOT STREET
|
||
|
STANFORD, KY 40484
|
||
|
(Address of principal executive offices) (Zip Code)
|
||
|
Large accelerated filer
☐
|
Accelerated filer
☐
|
|
|
|
|
Non-accelerated filer
☐
|
Smaller reporting company
☒
|
|
(Do not check if a smaller reporting company)
|
|
|
|
Emerging growth company
☐
|
|
PART I. Financial Information
|
3
|
|
Item 1. Financial Statements
|
3
|
|
Condensed Consolidated Balance Sheets
|
3
|
|
Condensed Consolidated Statements of Operations
|
4
|
|
Condensed Consolidated Statements of Comprehensive Income (Loss)
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Notes to Condensed Consolidated Financial Statements
|
7
|
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
|
17
|
|
Item 4. Controls and Procedures
|
21
|
|
PART II. Other Information
|
22
|
|
Item 1. Legal Proceedings
|
22
|
|
Item 1A. Risk Factors
|
22
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
22
|
|
Item 3. Defaults Upon Senior Securities
|
22
|
|
Item 4. Mine Safety Disclosures
|
22
|
|
Item 5. Other Information
|
22
|
|
Item 6. Exhibits
|
22
|
|
Signatures
|
23
|
|
Exhibit Index
|
24
|
|
March 31, 2018
|
December 31, 2017*
|
|||||||
|
ASSETS
|
||||||||
|
Investments:
|
||||||||
|
Investments available for sale:
|
||||||||
|
Fixed maturities, at fair value (amortized cost $164,891,063 and $159,912,511)
|
$
|
179,204,313
|
$
|
178,555,225
|
||||
|
Equity securities, at fair value (cost $0 and $35,712,633)
|
0
|
58,848,491
|
||||||
| Equity securities, at fair value (cost $43,566,804 and $0) |
70,831,898
|
0 | ||||||
|
Mortgage loans on real estate at amortized cost
|
15,310,336
|
17,314,477
|
||||||
|
Investment real estate
|
48,937,132
|
50,504,550
|
||||||
|
Notes receivable
|
18,440,090
|
19,004,016
|
||||||
|
Policy loans
|
9,597,632
|
9,559,142
|
||||||
|
Total investments
|
342,321,401
|
333,785,901
|
||||||
|
Cash and cash equivalents
|
19,955,662
|
25,434,199
|
||||||
|
Accrued investment income
|
3,348,297
|
2,990,721
|
||||||
|
Reinsurance receivables:
|
||||||||
|
Future policy benefits
|
26,421,164
|
26,488,346
|
||||||
|
Policy claims and other benefits
|
3,913,683
|
3,882,047
|
||||||
|
Cost of insurance acquired
|
6,226,776
|
6,428,292
|
||||||
|
Property and equipment, net of accumulated depreciation
|
1,009,824
|
1,118,826
|
||||||
|
Income tax recoverable
|
536,877
|
549,851
|
||||||
|
Other assets
|
433,494
|
5,766,901
|
||||||
|
Total assets
|
$
|
404,167,178
|
$
|
406,445,084
|
||||
|
LIABILITIES & SHAREHOLDERS' EQUITY
|
||||||||
|
Liabilities:
|
||||||||
|
Policy liabilities and accruals:
|
||||||||
|
Future policyholder benefits
|
$
|
258,010,660
|
$
|
259,469,205
|
||||
|
Policy claims and benefits payable
|
4,320,094
|
3,777,175
|
||||||
|
Other policyholder funds
|
438,187
|
408,790
|
||||||
|
Dividend and endowment accumulations
|
14,618,065
|
14,601,645
|
||||||
|
Deferred income taxes
|
10,989,278
|
10,996,404
|
||||||
|
Other liabilities
|
6,428,406
|
6,760,347
|
||||||
|
Total liabilities
|
294,804,690
|
296,013,566
|
||||||
|
Shareholders' equity:
|
||||||||
|
Common stock - no par value, stated value $.001 per share. Authorized 7,000,000 shares - 3,318,051 and 3,333,337 shares outstanding
|
3,318
|
3,333
|
||||||
|
Additional paid-in capital
|
37,165,939
|
37,536,164
|
||||||
|
Retained earnings
|
59,975,029
|
39,040,456
|
||||||
|
Accumulated other comprehensive income (loss)
|
11,289,621
|
32,952,338
|
||||||
|
Total UTG shareholders' equity
|
108,433,907
|
109,532,291
|
||||||
|
Noncontrolling interests
|
928,581
|
899,227
|
||||||
|
Total shareholders' equity
|
109,362,488
|
110,431,518
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
404,167,178
|
$
|
406,445,084
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
Revenue:
|
||||||||
|
Premiums and policy fees
|
$
|
2,649,971
|
$
|
2,702,754
|
||||
|
Ceded reinsurance premiums and policy fees
|
(738,965
|
)
|
(726,654
|
)
|
||||
|
Net investment income
|
3,068,118
|
3,036,484
|
||||||
|
Other income
|
60,935
|
115,959
|
||||||
|
Revenue before net investment gains (losses)
|
5,040,059
|
5,128,543
|
||||||
|
Net investment gains (losses):
|
||||||||
|
Other-than-temporary impairments
|
0
|
(484,347
|
)
|
|||||
|
Other realized investment gains, net
|
534,242
|
(14,344
|
)
|
|||||
|
Change in fair value of equity securities
|
4,129,236
|
0
|
||||||
|
Total net investment gains (losses)
|
4,663,478
|
(498,691
|
)
|
|||||
|
Total revenue
|
9,703,537
|
4,629,852
|
||||||
|
Benefits and other expenses:
|
||||||||
|
Benefits, claims and settlement expenses:
|
||||||||
|
Life
|
4,168,794
|
4,967,652
|
||||||
|
Ceded Reinsurance benefits and claims
|
(688,412
|
)
|
(286,110
|
)
|
||||
|
Annuity
|
256,884
|
243,397
|
||||||
|
Dividends to policyholders
|
126,999
|
113,286
|
||||||
|
Commissions and amortization of deferred policy acquisition costs
|
(40,571
|
)
|
(35,981
|
)
|
||||
|
Amortization of cost of insurance acquired
|
201,516
|
209,776
|
||||||
|
Operating expenses
|
2,085,819
|
2,046,057
|
||||||
|
Total benefits and other expenses
|
6,111,029
|
7,258,077
|
||||||
|
Income (loss) before income taxes
|
3,592,508
|
(2,628,225
|
)
|
|||||
|
Income tax expense (benefit)
|
905,763
|
(513,590
|
)
|
|||||
|
Net income (loss)
|
2,686,745
|
(2,114,635
|
)
|
|||||
|
Net (income) loss attributable to noncontrolling interests
|
(29,500
|
)
|
141,234
|
|||||
|
Net income (loss) attributable to common shareholders
|
$
|
2,657,245
|
$
|
(1,973,401
|
)
|
|||
|
Amounts attributable to common shareholders
|
||||||||
|
Basic income (loss) per share
|
$
|
0.80
|
$
|
(0.59
|
)
|
|||
|
Diluted income (loss) per share
|
$
|
0.80
|
$
|
(0.59
|
)
|
|||
|
Basic weighted average shares outstanding
|
3,325,111
|
3,350,248
|
||||||
|
Diluted weighted average shares outstanding
|
3,325,111
|
3,350,248
|
||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
Net income (loss)
|
$
|
2,686,745
|
$
|
(2,114,635
|
)
|
|||
|
Other comprehensive income (loss):
|
||||||||
|
Unrealized holding gains (losses) arising during period, pre-tax
|
(4,285,303
|
)
|
4,471,023
|
|||||
|
Tax (expense) benefit on unrealized holding gains (losses) arising during the period
|
899,914
|
(1,564,858
|
)
|
|||||
|
Unrealized holding gains (losses) arising during period, net of tax
|
(3,385,389
|
)
|
2,906,165
|
|||||
|
Less reclassification adjustment for gains included in net income
|
0
|
14,344
|
||||||
|
Tax expense for gains included in net income
|
0
|
(5,020
|
)
|
|||||
|
Reclassification adjustment for gains included in net income, net of tax
|
0
|
9,324
|
||||||
|
Subtotal: Other comprehensive income (loss), net of tax
|
(3,385,389
|
)
|
2,915,489
|
|||||
|
Comprehensive income (loss)
|
(698,644
|
)
|
800,854
|
|||||
|
Less comprehensive (income) loss attributable to noncontrolling interests
|
$
|
(29,500
|
)
|
$
|
141,234
|
|||
|
Comprehensive income (loss) attributable to UTG, Inc.
|
$
|
(728,144
|
)
|
$
|
942,088
|
|||
|
Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss) attributable to common shareholders
|
$
|
2,657,245
|
$
|
(1,973,401
|
)
|
|||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Amortization (accretion) of investments
|
17,036
|
84,656
|
||||||
|
Realized investment gains, net
|
(534,242
|
)
|
498,691
|
|||||
|
Change in fair value of equity securities
|
(4,129,236
|
)
|
0
|
|||||
|
Unrealized trading (gains) losses included in income
|
0
|
111,531
|
||||||
|
Realized trading (gains) included in income
|
0
|
(110,470
|
)
|
|||||
|
Amortization of cost of insurance acquired
|
201,516
|
209,776
|
||||||
|
Depreciation
|
275,143
|
175,471
|
||||||
|
Net income (loss) attributable to noncontrolling interest
|
29,500
|
(141,234
|
)
|
|||||
|
Charges for mortality and administration of universal life and annuity products
|
(1,650,201
|
)
|
(1,661,871
|
)
|
||||
|
Interest credited to account balances
|
883,563
|
1,092,176
|
||||||
|
Change in accrued investment income
|
(357,576
|
)
|
(191,914
|
)
|
||||
|
Change in reinsurance receivables
|
35,546
|
320,738
|
||||||
|
Change in policy liabilities and accruals
|
(6,961
|
)
|
3,707
|
|||||
|
Change in income taxes receivable (payable)
|
12,974
|
44,380
|
||||||
|
Change in other assets and liabilities, net
|
5,894,257
|
(1,038,724
|
)
|
|||||
|
Net cash provided by (used in) operating activities
|
3,328,564
|
(2,576,488
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds from investments sold and matured:
|
||||||||
|
Fixed maturities available for sale
|
14,515
|
2,614,087
|
||||||
|
Equity securities
|
103,298
|
0
|
||||||
|
Mortgage loans
|
2,009,715
|
290,019
|
||||||
|
Real estate
|
7,941,649
|
875,507
|
||||||
|
Notes receivable
|
563,926
|
99,787
|
||||||
|
Policy loans
|
366,847
|
528,338
|
||||||
|
Short-term investments
|
850,000
|
0
|
||||||
|
Total proceeds from investments sold and matured
|
11,849,950
|
4,407,738
|
||||||
|
Cost of investments acquired:
|
||||||||
|
Fixed maturities available for sale
|
(4,971,517
|
)
|
(1,977,627
|
)
|
||||
|
Equity securities
|
(7,957,471
|
)
|
(2,099,959
|
)
|
||||
|
Mortgage loans
|
0
|
(333,581
|
)
|
|||||
|
Real estate
|
(6,006,130
|
)
|
(446,391
|
)
|
||||
|
Notes receivable
|
0
|
(547,853
|
)
|
|||||
|
Policy loans
|
(405,337
|
)
|
(351,267
|
)
|
||||
|
Short-term investments
|
(850,000
|
)
|
0
|
|||||
|
Total cost of investments acquired
|
(20,190,455
|
)
|
(5,756,678
|
)
|
||||
|
Net cash provided by (used in) investing activities
|
(8,340,505
|
)
|
(1,348,940
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Policyholder contract deposits
|
1,149,533
|
1,242,214
|
||||||
|
Policyholder contract withdrawals
|
(1,245,743
|
)
|
(1,212,530
|
)
|
||||
|
Purchase of treasury stock
|
(600,240
|
)
|
(26,285
|
)
|
||||
|
Issuance of stock
|
230,000
|
197,488
|
||||||
|
Non controlling contributions (distributions) of consolidated subsidiary
|
(146
|
)
|
8,089
|
|||||
|
Net cash provided by (used in) financing activities
|
(466,596
|
)
|
208,976
|
|||||
|
Net increase (decreased) in cash and cash equivalents
|
(5,478,537
|
)
|
(3,716,452
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
25,434,199
|
15,156,548
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
19,955,662
|
$
|
11,440,096
|
||||
|
March 31, 2018
|
Original or Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Estimated Fair Value
|
||||||||||||
|
Investments available for sale:
|
||||||||||||||||
|
Fixed maturities
|
||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
7,652,991
|
$
|
20,049
|
$
|
(159,276
|
)
|
$
|
7,513,764
|
|||||||
|
U.S. special revenue and assessments
|
9,013,518
|
490,293
|
0
|
9,503,811
|
||||||||||||
|
All other corporate bonds
|
148,224,554
|
15,208,888
|
(1,246,704
|
)
|
162,186,738
|
|||||||||||
| $ |
164,891,063
|
$ |
15,719,230
|
$ |
(1,405,980
|
)
|
$ |
179,204,313
|
||||||||
|
December 31, 2017
|
Original or Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Estimated Fair Value
|
||||||||||||
|
Investments available for sale:
|
||||||||||||||||
|
Fixed maturities
|
||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
2,679,325
|
$
|
33,802
|
$
|
(73,530
|
)
|
$
|
2,639,597
|
|||||||
|
U.S. special revenue and assessments
|
9,012,232
|
620,789
|
0
|
9,633,021
|
||||||||||||
|
All other corporate bonds
|
148,220,954
|
18,359,816
|
(298,163
|
)
|
166,282,607
|
|||||||||||
|
159,912,511
|
19,014,407
|
(371,693
|
)
|
178,555,225
|
||||||||||||
|
Equity securities (1)
|
35,712,633
|
23,648,201
|
(512,343
|
)
|
58,848,491
|
|||||||||||
|
Total
|
$
|
195,625,144
|
$
|
42,662,608
|
$
|
(884,036
|
)
|
$
|
237,403,716
|
|||||||
|
Fixed Maturities Available for Sale
March 31, 2018
|
Amortized Cost
|
Estimated Fair Value
|
||||||
|
Due in one year or less
|
$
|
1,218,125
|
$
|
1,239,718
|
||||
|
Due after one year through five years
|
36,349,018
|
47,511,317
|
||||||
|
Due after five years through ten years
|
43,553,027
|
45,272,788
|
||||||
|
Due after ten years
|
83,770,893
|
85,180,490
|
||||||
|
Total
|
$
|
164,891,063
|
$
|
179,204,313
|
||||
|
March 31, 2018
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
|||||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
4,925,360
|
$
|
(47,756
|
)
|
$
|
1,567,604
|
$
|
(111,520
|
)
|
$
|
6,492,964
|
$
|
(159,276
|
)
|
|||||||||
|
All other corporate bonds
|
35,719,080
|
(764,493
|
)
|
6,463,651
|
(482,211
|
)
|
42,182,731
|
(1,246,704
|
)
|
|||||||||||||||
|
Total fixed maturities
|
$
|
40,644,440
|
$
|
(812,249
|
)
|
$
|
8,031,255
|
(593,731
|
)
|
$
|
48,675,695
|
(1,405,980
|
)
|
|||||||||||
|
December 31, 2017
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
|||||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
0
|
$
|
0
|
$
|
1,604,987
|
$
|
(73,530
|
)
|
$
|
1,604,987
|
$
|
(73,530
|
)
|
||||||||||
|
All other corporate bonds
|
9,732,635
|
(91,757
|
)
|
11,164,317
|
(206,406
|
)
|
20,896,952
|
(298,163
|
)
|
|||||||||||||||
|
Total fixed maturities
|
$
|
9,732,635
|
$
|
(91,757
|
)
|
$
|
12,769,304
|
(279,936
|
)
|
$
|
22,501,939
|
(371,693
|
)
|
|||||||||||
|
Equity securities (1)
|
$
|
4,130,260
|
$
|
(270,774
|
)
|
$
|
1,526,868
|
$
|
(241,569
|
)
|
$
|
5,657,128
|
$
|
(512,343
|
)
|
|||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
|||
|
As of March 31, 2018
|
|||||
|
Fixed maturities
|
24
|
6
|
30
|
||
|
As of December 31, 2017
|
|||||
|
Fixed maturities
|
6
|
6
|
12
|
||
|
Equity securities (1)
|
2
|
2
|
4
|
|
(1)
|
Effective January 1, 2018, the Company adopted ASU No. 2016-01 and equity securities are no longer classified as available-for-sale. Prior periods have not been restated to conform to the current presentation. See Note 2 to the Condensed Consolidated Financial Statements for additional information.
|
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2018
|
2017
|
|||||||
|
Realized gains on available-for-sale investments:
|
||||||||
|
Sales of fixed maturities
|
$
|
0
|
$
|
0
|
||||
|
Sales of equity securities
|
0
|
0
|
||||||
|
Other
|
534,242
|
0
|
||||||
|
Total realized gains
|
534,242
|
0
|
||||||
|
Realized losses on available-for-sale investments:
|
||||||||
|
Sales of fixed maturities
|
0
|
(14,344
|
)
|
|||||
|
Sales of equity securities
|
0
|
0
|
||||||
|
Other-than-temporary impairments
|
0
|
(484,347
|
)
|
|||||
|
Other
|
0
|
0
|
||||||
|
Total realized losses
|
0
|
(498,691
|
)
|
|||||
|
Net realized investment gains (losses)
|
534,242
|
(498,691
|
)
|
|||||
|
Change in fair value of equity securities:
|
||||||||
|
Change in fair value of equity securities sold during the period
|
0
|
0
|
||||||
|
Change in fair value of equity securities held at the end of the period
|
4,129,236
|
0
|
||||||
|
Change in fair value of equity securities
|
4,129,236
|
0
|
||||||
|
Net investment gains (losses)
|
$
|
4,663,478
|
$
|
(498,691
|
)
|
|||
|
Change in net unrealized gains (losses) on available-for-sale investments included in other comprehensive income:
|
||||||||
|
Fixed maturities
|
$
|
(4,285,303
|
)
|
$
|
3,033,099
|
|||
|
Equity securities (1)
|
0
|
1,423,580
|
||||||
|
Net increase (decrease)
|
$
|
(4,285,303
|
)
|
$
|
4,456,679
|
|||
| (1) |
Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income (loss). Prior periods have not been restated to conform to the current presentation. See note 2 to the Condensed Consolidated Financial Statements for additional information.
|
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2018
|
2017
|
|||||||
|
Other than temporary impairments:
|
||||||||
|
Real estate
|
$
|
0
|
$
|
484,347
|
||||
|
Total other than temporary impairments
|
$
|
0
|
$
|
484,347
|
||||
|
2018
|
2017
|
||||||
|
Maximum rate
|
Minimum rate
|
Maximum rate
|
Minimum rate
|
||||
|
Farm Loans
|
5.00%
|
5.00%
|
5.00%
|
5.00%
|
|||
|
Commercial Loans
|
7.50%
|
4.00%
|
7.50%
|
4.00%
|
|||
|
Residential Loans
|
8.00%
|
5.00%
|
8.00%
|
4.00%
|
|||
|
March 31, 2018
|
December 31, 2017
|
|||||||
|
In good standing
|
$
|
12,108,873
|
$
|
15,310,941
|
||||
|
Overdue interest over 90 days
|
3,201,463
|
0
|
||||||
|
Restructured
|
0
|
0
|
||||||
|
In process of foreclosure
|
0
|
2,003,536
|
||||||
|
Total mortgage loans
|
$
|
15,310,336
|
$
|
17,314,477
|
||||
|
Total foreclosed loans during the year
|
$
|
0
|
$
|
0
|
||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Fixed Maturities, available for sale
|
$
|
7,513,764
|
$
|
171,226,675
|
$
|
463,874
|
$
|
179,204,313
|
||||||||
|
Equity Securities
|
24,881,771
|
9,359,362
|
36,590,765
|
70,831,898
|
||||||||||||
|
Total
|
$
|
32,395,535
|
$
|
180,586,037
|
$
|
37,054,639
|
$
|
250,036,211
|
||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Fixed Maturities, available for sale
|
$
|
2,639,597
|
$
|
175,437,239
|
$
|
478,389
|
$
|
178,555,225
|
||||||||
|
Equity Securities, available for sale (1)
|
20,436,225
|
7,756,435
|
30,655,831
|
58,848,491
|
||||||||||||
|
Total
|
$
|
23,075,822
|
$
|
183,193,674
|
$
|
31,134,220
|
$
|
237,403,716
|
||||||||
|
Fixed Maturities,
Available for Sale
|
Equity Securities (1)
|
Total
|
||||||||||
|
Balance at December 31, 2017
|
$
|
478,389
|
$
|
30,655,831
|
$
|
31,134,220
|
||||||
|
Total unrealized gain or (losses):
|
||||||||||||
|
Included in net income (loss)
|
0
|
778,984
|
778,984
|
|||||||||
|
Included in other comprehensive income
|
(14,515
|
)
|
0
|
(14,515
|
)
|
|||||||
|
Purchases
|
0
|
5,259,250
|
5,259,250
|
|||||||||
|
Sales
|
0
|
(103,300
|
)
|
(103,300
|
)
|
|||||||
|
Balance at March 31, 2018
|
$
|
463,874
|
$
|
36,590,765
|
$
|
37,054,639
|
||||||
|
(1)
|
Effective January 1, 2018, the Company adopted ASU No. 2016-01 and equity securities are no longer classified as available-for-sale. Prior periods have not been restated to conform to the current presentation. See Note 2 to the Condensed Consolidated Financial Statements for additional information.
|
|
March 31, 2018
|
December 31, 2017
|
|||||||
|
Change in fair value of equity securities included in net income (loss) relating to assets held
|
$
|
778,984
|
$
|
0
|
||||
|
March 31, 2018
|
December 31, 2017
|
|||||||||||||||
|
Assets
|
Carrying Amount
|
Estimated Fair Value
|
Carrying Amount
|
Estimated Fair Value
|
||||||||||||
|
Mortgage loans on real estate
|
$
|
15,310,336
|
$
|
15,310,336
|
$
|
17,314,477
|
$
|
17,314,477
|
||||||||
|
Investment real estate
|
48,937,132
|
48,937,132
|
50,504,550
|
50,504,550
|
||||||||||||
|
Notes receivable
|
18,440,090
|
18,440,090
|
19,004,016
|
19,004,016
|
||||||||||||
|
Policy loans
|
9,597,632
|
9,597,632
|
9,559,142
|
9,559,142
|
||||||||||||
|
Cash and cash equivalents
|
19,955,662
|
19,955,662
|
25,434,199
|
25,434,199
|
||||||||||||
|
Instrument
|
Issue Date
|
Maturity Date
|
Revolving Credit Limit
|
December 31, 2017
|
Borrowings
|
Repayments
|
March 31, 2018
|
|||||||||||||||
|
Lines of Credit:
|
||||||||||||||||||||||
|
UTG
|
11/20/2013
|
11/20/2018
|
$
|
8,000,000
|
$
|
-
|
-
|
-
|
$
|
-
|
||||||||||||
|
UG
|
6/2/2015
|
5/10/2018
|
10,000,000
|
-
|
-
|
-
|
-
|
|||||||||||||||
|
Total Funding
Commitment
|
Unfunded
Commitment
|
|||||||
|
Sovereign's Capital, LP Fund I
|
$
|
500,000
|
$
|
30,000
|
||||
|
Sovereign's Capital, LP Fund II
|
1,000,000
|
397,914
|
||||||
|
Barton Springs Music, LLC
|
2,500,000
|
1,024,813
|
||||||
|
Master Mineral Holdings III, LP
|
4,000,000
|
3,500,000
|
||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2018
|
2017
|
|||||||
|
Interest
|
$
|
-
|
$
|
-
|
||||
|
Federal income tax
|
-
|
-
|
||||||
|
|
Three Months Ended March 31,
|
||||
|
2018
|
2017
|
||||
|
Net investment income
|
$
|
3,068,118
|
$
|
3,036,484
|
|
|
Net investment gains (losses)
|
$
|
4,663,478
|
$
|
(498,691)
|
|
|
Change in net unrealized investment gains (losses)- on available-for-sale securities
|
$
|
(4,285,303)
|
$
|
4,456,679
|
|
|
Three Months Ended
|
|||||
|
March 31,
|
|||||
|
2018
|
2017
|
||||
|
Fixed maturities available for sale
|
$
|
1,837,844
|
$
|
2,121,877
|
|
|
Equity securities
|
532,067
|
381,863
|
|||
|
Trading securities
|
0
|
(1,061)
|
|||
|
Mortgage loans
|
214,558
|
228,060
|
|||
|
Real estate
|
449,546
|
469,258
|
|||
|
Notes receivable
|
386,782
|
320,711
|
|||
|
Policy loans
|
150,081
|
155,353
|
|||
|
Short-term
|
48,172
|
0
|
|||
|
Cash and cash equivalents
|
12,434
|
2,580
|
|||
|
Total consolidated investment income
|
3,631,484
|
3,678,641
|
|||
|
Investment expenses
|
(563,366)
|
(642,157)
|
|||
|
Consolidated net investment income
|
$
|
3,068,118
|
$
|
3,036,484
|
|
|
*31.1
|
Certification of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*31.2
|
Certification of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*32.1
|
Certificate of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
*32.2
|
Certificate of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
**101
|
Interactive Data File
|
|
Date:
|
May 14, 2018
|
By
|
/s/ James P. Rousey
|
|
|
James P. Rousey
|
||||
|
President and Director
|
|
Date:
|
May 14, 2018
|
By
|
/s/ Theodore C. Miller
|
|
|
Theodore C. Miller
|
||||
|
Senior Vice President
|
||||
|
and Chief Financial Officer
|
|
Exhibit Number
|
Description
|
|
*31.1
|
Certification of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*31.2
|
Certification of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*32.1
|
Certificate of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
*32.2
|
Certificate of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
**101
|
Interactive Data File
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|